What is Ramucirumab?

Category: Prescription Drugs

Most popular types: Cyramza


Ramucirumab is an injectable anti-cancer agent that is used to treat advanced gastric cancer, gastro-esophageal junction adenocarcinoma, and certain types of non-small cell lung cancer.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 1
None 0

Commonly reported side effects and conditions associated with Ramucirumab

Side effect Patients
Fluid retention (edema) 1
Muscle spasms in lower back 1
Nosebleeds (epistaxis) 1
Tongue sores 1


Based on patients currently taking Ramucirumab

Dosage Patients
625 mg every 3 weeks 1


Currently taking Ramucirumab

Duration Patients
1 - 2 years 1
2 - 5 years 1
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1

What people switch to and from

Patients started taking Ramucirumab after stopping:

Treatment Patients
Chemotherapy 1
Docetaxel (Taxotere) 1
Pemetrexed (Alimta) 1
Last updated:
There are no evaluations for Ramucirumab.